关注
Kavya Swarna
Kavya Swarna
Health Services Analyst, Mayo Clinic
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Sociodemographic, clinical, and treatment-related factors associated with hyperglycemic crises among adults with type 1 or type 2 diabetes in the US from 2014 to 2020
RG McCoy, RJ Galindo, KS Swarna, HK Van Houten, PJ O’Connor, ...
JAMA network open 4 (9), e2123471-e2123471, 2021
462021
Infection-related hospitalization following ureteroscopic stone treatment: results from a surgical collaborative
A Cole, J Telang, TK Kim, K Swarna, J Qi, C Dauw, B Seifman, ...
BMC urology 20, 1-7, 2020
182020
Rates of hypoglycemic and hyperglycemic emergencies among US adults with diabetes, 2011–2020
RG McCoy, J Herrin, RJ Galindo, KS Swarna, GE Umpierrez, SH Golden, ...
Diabetes care 46 (2), e69-e71, 2023
172023
Shockwave lithotripsy use in the state of Michigan: American Urological Association guideline adherence and clinical implications
CA Dauw, K Swarna, J Qi, T Kim, D Leavitt, J Leese, M Abdelhady, ...
Urology 137, 38-44, 2020
122020
Derivation of an annualized claims-based major adverse cardiovascular event estimator in type 2 diabetes
RG McCoy, KS Swarna, Y Deng, JS Herrin, JS Ross, DM Kent, BJ Borah, ...
JACC: Advances 3 (4), 100852, 2024
82024
All-cause mortality after hypoglycemic and hyperglycemic emergencies among US adults with diabetes, 2011–2020
RG McCoy, J Herrin, RJ Galindo, KS Swarna, GE Umpierrez, SH Golden, ...
Diabetes research and clinical practice 197, 110263, 2023
82023
Disparities in Acute and Chronic Complications of Diabetes Along the US Rural-Urban Continuum
K Steiger, J Herrin, KS Swarna, EM Davis, RG McCoy
Diabetes care 47 (5), 818-825, 2024
62024
Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
RG McCoy, J Herrin, KS Swarna, Y Deng, DM Kent, JS Ross, ...
Nature cardiovascular research 3 (4), 431-440, 2024
42024
Comparative effectiveness of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, dipeptidyl peptidase-4 inhibitors, and sulfonylureas for …
AJ Barkmeier, J Herrin, KS Swarna, Y Deng, EC Polley, GE Umpierrez, ...
Ophthalmology Retina 8 (10), 943-952, 2024
32024
Enrollment in High-Deductible Health Plans and Incident Diabetes Complications
RG McCoy, KS Swarna, DH Jiang, HK Van Houten, J Chen, EM Davis, ...
JAMA Network Open 7 (3), e243394-e243394, 2024
22024
Benefit of anticoagulation early after surgical aortic valve replacement using bioprosthetic valves
Y Huang, HV Schaff, KS Swarna, LR Sangaralingham, RA Nishimura, ...
Mayo Clinic Proceedings 98 (12), 1797-1808, 2023
22023
PD26-06 shockwave lithotripsy and ureteroscopy for the treatment of lower pole stones: Results from a statewide clinical registry
E Stockall, J Shannon, C Dauw, K Swarna, J Telang, T Kim, J Leese, ...
Journal of Urology 201, e476-e477, 2019
22019
MP33-17 USING A CLINICAL REGISTRY AND MACHINE LEARNING TO PREDICT URETERAL STENT PLACEMENT FOLLOWING URETEROSCOPY
M Inadomi*, K Ghani, T Kim, C Dauw, J Hollingsworth, D Leavitt, A Murali, ...
The Journal of Urology 201 (Supplement 4), e460-e460, 2019
22019
Patients with inflammatory bowel disease are at increased risk for complications of herpes zoster
F Caldera, S Singh, EE Zona, OR Ramirez, J Inselman, H Heien, ...
Clinical Gastroenterology and Hepatology, 2024
12024
Anticoagulation after bioprosthetic aortic valve replacement: are we following the guidelines?
Y Huang, HV Schaff, KS Swarna, LR Sangaralingham, RA Nishimura, ...
The Annals of Thoracic Surgery 115 (3), 619-625, 2023
12023
1026-P: Rates and Disparities of Hypoglycemic and Hyperglycemic Emergencies and Mortality among US Adults with Diabetes, 2009-2018
RG MCCOY, KS SWARNA, RJ GALINDO, H VAN HOUTEN, ...
Diabetes 70 (Supplement_1), 2021
12021
PD01-09 URETERAL STENT PLACEMENT FOLLOWING URETEROSCOPY INCREASES EMERGENCY DEPARTMENT VISITS IN A STATEWIDE QUALITY IMPROVEMENT INITIATIVE
SC Hiller, K Swarna, J Slayton, H Pimentel, J Ludlow, S Ambani, ...
Journal of Urology 203, e63, 2020
12020
Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for …
AJ Barkmeier, J Herrin, KS Swarna, Y Deng, EC Polley, GE Umpierrez, ...
Ophthalmology Retina 8 (10), 943-952, 2024
2024
Risk of Severe Hypoglycemia After Initiation of Noninsulin Glucose-Lowering Therapies in Adults With Type 2 Diabetes at Moderate Cardiovascular Disease Risk
RG McCoy, KS Swarna, JJ Neumiller, EC Polley, Y Deng, MM Mickelson, ...
Clinical Diabetes, cd240007, 2024
2024
413-P: Comparative Effectiveness of Glucose-Lowering Agents on Kidney Outcomes in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk
JJ NEUMILLER, J HERRIN, K SWARNA, E POLLEY, RJ GALINDO, ...
Diabetes 73 (Supplement_1), 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–20